SUN PHARM INDS INC FDA Approval ANDA 076416

ANDA 076416

SUN PHARM INDS INC

FDA Drug Application

Application #076416

Application Sponsors

ANDA 076416SUN PHARM INDS INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORALEQ 2MG BASE0TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
002TABLET;ORALEQ 4MG BASE0TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2003-09-29
LABELING; LabelingSUPPL3AP2007-03-22
LABELING; LabelingSUPPL4AP2007-09-25
LABELING; LabelingSUPPL13AP2014-12-14STANDARD

Submissions Property Types

SUPPL13Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

SUN PHARM INDS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 76416
            [companyName] => SUN PHARM INDS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TIZANIDINE HYDROCHLORIDE","activeIngredients":"TIZANIDINE HYDROCHLORIDE","strength":"EQ 2MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TIZANIDINE HYDROCHLORIDE","activeIngredients":"TIZANIDINE HYDROCHLORIDE","strength":"EQ 4MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TIZANIDINE HYDROCHLORIDE","submission":"TIZANIDINE HYDROCHLORIDE","actionType":"EQ 2MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"TIZANIDINE HYDROCHLORIDE","submission":"TIZANIDINE HYDROCHLORIDE","actionType":"EQ 4MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.